Snapshot from Jul 05, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / International AIDS Vaccine Initiative / Mapp Biopharmaceutical

International AIDS Vaccine Initiative & Mapp Biopharmaceutical

1 shared events · Importance 3 · Last updated Jun 30, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
50
International
Africa CDC Seeks Ebola Funding
International AIDS Vaccine Initiative: The International AIDS Vaccine Initiative is collaborating with the United States — Centers for Disease Control and Prevention and other partners in the scientific mobilization against the Ebola strain.
Mapp Biopharmaceutical: Mapp Biopharmaceutical is developing an antibody, MBP134, which is being evaluated in the clinical trials to reduce mortality among infected Ebola patients.
Jun 30, 2026 · 6 articles
NEWSDESK
Explore this relationship live

Track how International AIDS Vaccine Initiative and Mapp Biopharmaceutical interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.